Randall Stanicky analyst

Currently out of the existing stock ratings of Randall Stanicky, 84 are a HOLD (35.15%), 149 are a BUY (62.34%), 6 are a SELL (2.51%).

Randall Stanicky

Work Performance Price Targets & Ratings Chart

Analyst Randall Stanicky, carries an average stock price target met ratio of 43.12% that have a potential upside of 38.19% achieved within 396 days. Previously, Randall Stanicky worked at RBC, CANACCORD.

Randall Stanicky’s has documented 478 price targets and ratings displayed on 28 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on EGRX, Eagle Pharmaceuticals at 07-Apr-2021.

Wall Street Analyst Randall Stanicky

Analyst best performing recommendations are on AGRX (AGILE THRPE).
The best stock recommendation documented was for AGRX (AGILE THRPE) at 10/31/2019. The price target of $4000 was fulfilled within 5 days with a profit of $1600 (66.67%) receiving and performance score of 133.33.

Average potential price target upside

ABBV AbbVie ACRX AcelRx Pharmaceuticals AGN Allergan plc AGRX Agile Thrpe AKRX Akorn AMRX Amneal Pharmaceuticals, Common Stock EGRX Eagle Pharmaceuticals ENDP Endo International PLC FLXN Flexion Therapeutics INSY INSYS Therapeutics JAZZ Jazz Pharmaceuticals PLC KMPH KemPharm MRK Merck mpany MYL Viatris OSMT Osmotica Pharmaceuticals plc PCRX Pacira Pharmaceuticals PFE Pfizer PRGO Perrigo Company PLC SGNT Sagent Pharmaceuticals TEVA Teva Pharma Industries Ltd ADR VTRS Viatris XERS Xeris Pharmaceuticals AQST Aquestive Therapeutics ASRT Assertio Therapeutics NEOS Neos Therapeutics OPTN OptiNose RVLP RVL Pharmaceuticals PLC OS OneStream, Common Stock

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 16-May-2024

$320

$53.31 (19.99%)

$200

Buy Since 09-Sep-2026

$315

$48.31 (18.11%)

$265

27 days ago
(09-Sep-2026)

5/6 (83.33%)

$60 (23.53%)

131

Buy Since 11-Sep-2025

$303

$36.31 (13.62%)

$298

1 months 17 days ago
(19-Aug-2026)

2/11 (18.18%)

$41.17 (15.72%)

35

Buy Since 07-Dec-2021

$300

$33.31 (12.49%)

$295

1 months 20 days ago
(16-Aug-2026)

10/12 (83.33%)

$49.67 (19.84%)

514

Hold Since 12-Aug-2026

$300

$33.31 (12.49%)

1 months 24 days ago
(12-Aug-2026)

1/2 (50%)

$49.18 (19.61%)

115

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?